Correction to: Ambrisentan ± tadalafil in WHO functional class II/III pulmonary arterial hypertension: a guide to its use in the EU
Crossref DOI link: https://doi.org/10.1007/s40267-018-0586-z
Published Online: 2018-11-23
Published Print: 2019-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lyseng-Williamson, Katherine A. http://orcid.org/0000-0002-5104-1158
Behr, Jürgen
Text and Data Mining valid from 2018-11-23
Article History
First Online: 23 November 2018